Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults. The post FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke appeared first on MedCity News.

Healthcare has plenty of tedious administrative work which could benefit from AI’s efficiency – but what if simply speeding up an already broken system isn’t the answer? Healthcare leaders push for a re-built, AI-native system in Anterior’s recent Beyond Faster Horses campaign. The post New Campaign Wants AI Applications To Look Beyond Speed appeared first on MedCity News.

The industry’s next major competitor may never build another national laboratory network or employ thousands of phlebotomists. It may simply own the device that notices something first. The post The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist appeared first on MedCity News.

Avanlee Care’s seed round was led by BEA Venture Fund, with participation from existing investors, including Board Chair Esther Dyson, Chrysalis Ventures and FairBridge VC. The post Startup Supporting Caregivers Raises $3.5M in Seed Funding appeared first on MedCity News.

In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist two-to-three years from now. The post Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health” appeared first on MedCity News.

Argenx’s Unnatural Products acquisition brings a macrocyclic peptides discovery platform for developing oral peptide drugs. The deal brings a new modality to Argenx, whose immunology R&D had focused on antibodies. The post Argenx Adds Oral Peptides to Its Immunology Strategy With $550M UNP Acquisition appeared first on MedCity News.

Simulations do not replace human judgment: they inform it, making transparent what would otherwise remain a “black box.” EU law does not require them today; but a proportionate embrace, in the right legislative vehicle, with clear methodological standards, and without crushing noncommercial research, could make trials safer, faster, cheaper, and more reliable, without sacrificing rigor. The post Simulation-Guided Clinical Trials: Is EU Law Ready? appeared first on MedCity News.

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic sclerosis, during the American College of Rheumatology annual in Orlando this week. The biotech is part of a growing group of companies developing therapies that reset the immune system to treat autoimmune disease. The post Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy appeared first on MedCity News.

Patients increasingly expect convenient, consumer-focused healthcare experiences, panelists said at the recent MedCity INVEST Digital Health Conference. The post What’s Driving the Consumerization of Healthcare? appeared first on MedCity News.

Treating AI agents like contract nurses and minimizing their access to critical patient information certainly reduces potential risk. But, it also minimizes key opportunities. The post Missing the Point: Isolation Alone Will Not Build AI Safety appeared first on MedCity News.

Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The bispecific antibody was initially approved for treating certain lung cancers. The post Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer appeared first on MedCity News.

A new Experian Health survey finds that healthcare providers’ efforts to prevent claims denials are falling short, with many reporting an increase in denials over last year and increasingly complex payer requirements. The post Experian Health Survey: Providers Struggle Amid Increasing Claim Denials appeared first on MedCity News.

Typically, software placed on the market will undergo changes and updates after its initial release. In the case of healthcare AI, changes can occur, often unexpectedly, even when the developers have not updated the model. The post The Big Challenge for AI in Healthcare Comes After Approval appeared first on MedCity News.

One voice needs to be increasingly present in the rooms where healthcare’s future is being decided: the physician’s. The post Why Physician Leadership Is More Important Than Ever appeared first on MedCity News.

Customer discovery is a well accepted idea in any innovation process. At the core of it, it means talking to potential customers about an invention. In reality, it is a more evolved process, and often less understood than it first appears. The post Myths of Customer Discovery appeared first on MedCity News.